Skip to main content
. 2014 Jul 23;2014:754678. doi: 10.1155/2014/754678

Table 1.

Characteristics of the participants with hyperuricemia and those without.

Characteristics Men (n = 848) Women (n = 1254)   Total
   (n = 2102)
Hyperuricemia (n = 148) No hyperuricemia (n = 700) P value Subtotal Hyperuricemia (n = 204) No hyperuricemia (n = 1050) P value Subtotal
x-±s
 Age (yrs) 73.5 ± 6.9 72.1 ± 6.8 0.028 72.3 ± 6.9 71.8 ± 6.0 70.1 ± 6.3 0.001 70.4 ± 6.2 71.2 ± 6.6
 WC (cm) 94.0 ± 8.4 90.6 ± 8.4 <0.001 91.2 ± 8.5 90.3 ± 9.5 85.6 ± 8.6 <0.001 86.4 ± 8.9 88.3 ± 9.1
 BMI (kg/m2) 25.7 ± 3.0 24.8 ± 3.1 0.002 24.9 ± 3.1 26.4 ± 3.8 24.8 ± 3.5 <0.001 25.0 ± 3.6 25.0 ± 3.4
 SBP (mmHg) 136.8 ± 17.5 136.6 ± 18.0 0.927 136.7 ± 17.9 141.9 ± 20.4 140.2 ± 20.9 0.285 140.5 ± 20.8 139.0 ± 19.8
 DBP (mmHg) 77.4 ± 9.4 78.6 ± 9.7 0.191 78.4 ± 9.7 75.9 ± 10.4 76.8 ± 9.9 0.273 76.6 ± 10.0 77.3 ± 9.9
 TC (mmol/L)a 5.0 ± 1.1 4.9 ± 0.9 0.131 4.9 ± 0.9 5.5 ± 1.0 5.5 ± 1.0 0.550 5.5 ± 1.0 5.3 ± 1.0
 TG (mmol/L) 1.8 ± 1.0 1.5 ± 0.8 0.001 1.5 ± 0.9 2.1 ± 1.0 1.7 ± 0.9 <0.001 1.8 ± 0.9 1.7 ± 0.9
 HDL-C (mmol/L) 1.2 ± 0.3 1.3 ± 0.4 0.016 1.3 ± 0.4 1.4 ± 0.4 1.5 ± 0.4 <0.001 1.5 ± 0.4 1.4 ± 0.4
 LDL-C (mmol/L)b 3.1 ± 0.9 3.0 ± 0.8 0.338 3.1 ± 0.8 3.4 ± 0.8 3.4 ± 0.9 0.506 3.4 ± 0.9 3.3 ± 0.8
 FBG (mmol/L) 6.0 ± 1.3 6.1 ± 1.6 0.428 6.1 ± 1.5 6.1 ± 1.3 6.1 ± 1.8 0.704 6.1 ± 1.8 6.1 ± 1.7
 2hPG (mmol/L) 8.1 ± 2.6 8.2 ± 3.0 0.707 8.2 ± 3.0 9.2 ± 3.3 8.2 ± 3.3 <0.001 8.4 ± 3.3 8.3 ± 3.2
 SUA (mg/dL) 7.9 ± 0.8 5.4 ± 0.9 <0.001 5.8 ± 1.3 7.0 ± 1.0 4.5 ± 0.8 <0.001 4.9 ± 1.2 5.3 ± 1.4
n (%)
 Education (≥6 yrs) 124 (83.8) 576 (82.3) 0.663 700 (82.5) 142 (69.6) 680 (64.8) 0.183 822 (65.6) 1522 (72.4)
 Married 131 (88.5) 650 (92.9) 0.075 781 (92.1) 157 (77.0) 836 (79.6) 0.392 993 (79.2) 1774 (84.4)
 Current smoking 27 (18.2) 153 (21.9) 0.329 180 (21.2) 7 (3.4) 44 (4.2) 0.615 51 (4.1) 231 (11.1)
 Current drinking 58 (39.2) 267 (38.1) 0.812 325 (38.3) 14 (6.9) 86 (8.2) 0.522 100 (8.0) 425 (20.2)
 PA (≥0.5 h/day) 88 (59.5) 422 (60.3) 0.852 510 (60.1) 121 (59.3) 603 (57.4) 0.618 724 (57.7) 1234 (58.7)
 Family history of CVD 84 (56.8) 453 (64.7) 0.068 537 (63.3) 122 (59.8) 639 (60.9) 0.778 761 (60.7) 1298 (61.8)
 Medication for hypertension 76 (51.4) 278 (39.7) 0.009 354 (41.7) 125 (61.3) 493 (47.0) <0.001 618 (49.3) 972 (46.2)
 Medication for diabetes 23 (15.5) 119 (17.0) 0.666 142 (16.7) 39 (19.1) 180 (17.1) 0.497 219 (17.5) 361 (17.2)
 Medication for hyperlipidemia 31 (20.9) 86 (12.3) 0.006 117 (13.8) 38 (18.6) 147 (14.0) 0.088 185 (14.8) 302 (14.4)
 MetS 93 (62.8) 332 (47.4) 0.001 425 (50.1) 168 (82.4) 649 (61.8) <0.001 817 (65.2) 1242 (59.1)

Data are x-±s for continuous values or n (%) for category values; aTC: total cholesterol; bLDL-C: low density-lipoprotein cholesterol.